These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6111518)

  • 1. Catecholamine turnover in rat cerebral cortex and caudate following repeated treatment with dihydroergotoxine.
    Cvejić V; Mrsulja BB
    Gerontology; 1981; 27(1-2):7-12. PubMed ID: 6111518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study.
    Versteeg DH; Kovács GL; Bohus B; de Kloet ER; de Wied D
    Brain Res; 1982 Jan; 231(2):343-51. PubMed ID: 6120024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.
    Sawynok J; Reid A
    Neurochem Res; 1986 May; 11(5):723-31. PubMed ID: 2873522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive avoidance performance correlates with catecholamine turnover in discrete limbic brain regions.
    Kovács GL; Versteeg DH; de Kloet ER; Bohus B
    Life Sci; 1981 Mar; 28(10):1109-16. PubMed ID: 6112649
    [No Abstract]   [Full Text] [Related]  

  • 5. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipsapirone, a new anxiolytic drug, stimulates catecholamine turnover in various regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1990; 42(2):143-50. PubMed ID: 1980361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of specific brain nuclei in which catecholamine turnover is increased by left ventricular receptors during acute myocardial infarction in the rat.
    Sole MJ; Hussain MN; Versteeg DH; de Kloet ER; Adams D; Lixfeld W
    Brain Res; 1982 Mar; 235(2):315-25. PubMed ID: 7188330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some problems encountered in attempting to estimate catecholamine turnover using lbbelled tyrosine.
    Persson T; Waldeck B
    J Pharm Pharmacol; 1970 Jul; 22(7):473-8. PubMed ID: 4395050
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in levels of dopamine and tyramine in the rat caudate nucleus following alterations in impulse flow in the nigrostriatal pathway.
    Jones RS; Juorio AV; Boulton AA
    J Neurochem; 1983 Feb; 40(2):396-401. PubMed ID: 6130125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1992 Jan; 260(1):343-8. PubMed ID: 1346163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine.
    Vathy I; Rimanoczy A; Eaton RC; Katay L
    Brain Res; 1994 Oct; 662(1-2):209-15. PubMed ID: 7859073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of 1-[2-[bis(fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on turnover of dopamine and norepinephrine in the brain].
    Nagase T; Ishiko J; Takaori S
    Nihon Yakurigaku Zasshi; 1987 Aug; 90(2):105-14. PubMed ID: 3119439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma catecholamine responses to tyrosine hydroxylase inhibition and cold exposure.
    Avakian EV; Horvath SM
    Life Sci; 1980 May; 26(20):1691-6. PubMed ID: 6104766
    [No Abstract]   [Full Text] [Related]  

  • 16. The lateral and medial median eminence: distribution of dopamine, norepinephrine, and luteinizing hormone-releasing hormone and the effect of prolactin on catecholamine turnover.
    Selmanoff M
    Endocrinology; 1981 May; 108(5):1716-22. PubMed ID: 6111445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine alterations in experimental hydrocephalus.
    Miyake H; Eghwrudjakpor PO; Sakamoto T; Mori K
    Childs Nerv Syst; 1992 Aug; 8(5):243-6. PubMed ID: 1394262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-methyl-para-tyrosine on monoamine levels in the Japanese quail: sex differences and testosterone effects.
    Balthazart J; Foidart A; Sante P; Hendrick JC
    Brain Res Bull; 1992 Feb; 28(2):275-88. PubMed ID: 1350749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine-angiotensin II receptor interaction in primary cultures of rat brain.
    Sumners C; Raizada MK
    Am J Physiol; 1984 May; 246(5 Pt 1):C502-9. PubMed ID: 6144276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.